Business ❯ Healthcare ❯ Pharmaceuticals

Market Trends

Novo Nordisk GLP-1 Drugs Revenue Growth Sales Performance Product Launches Vaccine Industry Consumer Health Obesity Medications Generic Products Acquisitions Investor Relations Growth Predictions Weight-Loss Treatments Weight Management Vaccine Development Sales Projections Company Strategies COVID-19 Impact Pulmonary Arterial Hypertension Obesity Drug Market Investment Strategies Corporate Health Initiatives Industry Challenges Insulin Products Consumer Health Products Obesity Treatment Revenue Projections Weight Loss Drugs

Pfizer CFO Dave Denton to Exit and Cecile Guegan Named Interim

The change raises investor concern about near-term guidance and succession as Pfizer integrates recent acquisitions and prepares to enter the obesity drug market.

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

Novo Nordisk Strikes Hims & Hers Deal for Ozempic and Wegovy, Drops Patent Suit

Sanofi Replaces Paul Hudson, Names Belén Garijo as Next CEO

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone